- Report
- May 2020
- 482 Pages
Global
From €9169EUR$9,500USD£7,866GBP
- Report
- August 2022
- 119 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- June 2021
- 50 Pages
China
From €2510EUR$2,600USD£2,153GBP
- Report
- June 2019
- 679 Pages
Global
€21234EUR$22,000USD£18,215GBP
- Report
- March 2021
- 94 Pages
Global
€21234EUR$22,000USD£18,215GBP
- Report
- August 2018
- 29 Pages
Global
From €1061EUR$1,099USD£910GBP
- Drug Pipelines
- January 2018
- 16 Pages
Global
From €9652EUR$10,000USD£8,279GBP
- Report
- January 2021
- 65 Pages
Asia Pacific
From €1448EUR$1,500USD£1,242GBP
- Report
- September 2023
- 239 Pages
China
From €3861EUR$4,000USD£3,312GBP
- Report
- September 2023
- 69 Pages
China
From €1737EUR$1,800USD£1,490GBP
- Report
- July 2023
- 123 Pages
China
From €1737EUR$1,800USD£1,490GBP
- Report
- April 2023
- 129 Pages
Global
€4826EUR$5,000USD£4,140GBP
- Report
- March 2024
- 115 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- July 2023
- 97 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- April 2023
- 89 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- January 2024
- 93 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Drug Pipelines
- August 2018
- 74 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Report
- April 2024
- 50 Pages
Global
From €2558EUR$2,650USD£2,194GBP
- Report
- July 2023
- 244 Pages
China
From €3861EUR$4,000USD£3,312GBP
- Report
- November 2021
- 747 Pages
Global
From €3861EUR$4,000USD£3,312GBP
Docetaxel is a chemotherapy drug used in the treatment of various types of cancer, including breast, ovarian, and non-small cell lung cancer. It is a semi-synthetic derivative of a natural substance found in the bark of the European yew tree. Docetaxel works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs.
Docetaxel is a widely used oncology drug, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in the treatment of advanced or metastatic cancer, and is sometimes used in combination with other drugs to improve the effectiveness of treatment.
Some companies in the Docetaxel market include Bristol-Myers Squibb, Pfizer, and Sanofi. Show Less Read more